Aurinia Pharmaceuticals Inc. financial data

Symbol
AUPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
#140, 14315 118 Avenue, Edmonton, Alberta, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 551 % -27.9%
Quick Ratio 51.7 % -5.57%
Debt-to-equity 43.5 % +53.8%
Return On Equity -6.05 % +69%
Return On Assets -4.22 % +72.3%
Operating Margin -14.8 % +73.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 143M shares -0.3%
Common Stock, Shares, Outstanding 143M shares -0.35%
Entity Public Float 1.38B USD -2.82%
Weighted Average Number of Shares Outstanding, Basic 143M shares +0.14%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +1.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 220M USD +38.7%
Cost of Revenue 28.1M USD +178%
Research and Development Expense 22.9M USD -53.5%
General and Administrative Expense 185M USD -3.83%
Costs and Expenses 253M USD +1.64%
Operating Income (Loss) -32.7M USD +63.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -20.1M USD +73.6%
Income Tax Expense (Benefit) 2.41M USD +155%
Net Income (Loss) Attributable to Parent -22.6M USD +70.8%
Earnings Per Share, Basic -0.15 USD/shares +71.7%
Earnings Per Share, Diluted -0.15 USD/shares +71.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 36.6M USD -19.6%
Inventory, Net 38.7M USD +18%
Other Assets, Current 2.7M USD +64.1%
Assets, Current 440M USD +3.28%
Property, Plant and Equipment, Net 2.89M USD -17.4%
Operating Lease, Right-of-Use Asset 4.18M USD -9.33%
Other Assets, Noncurrent 868K USD -42.8%
Assets 549M USD -1.02%
Employee-related Liabilities, Current 14.2M USD -22%
Contract with Customer, Liability, Current 4.3M USD -7.68%
Liabilities, Current 78.6M USD +6.39%
Operating Lease, Liability, Noncurrent 5.95M USD -11.4%
Other Liabilities, Noncurrent 10.8M USD +4.87%
Liabilities 161M USD -1.09%
Accumulated Other Comprehensive Income (Loss), Net of Tax -385K USD +59.3%
Retained Earnings (Accumulated Deficit) -938M USD -2.46%
Stockholders' Equity Attributable to Parent 388M USD -0.99%
Liabilities and Equity 549M USD -1.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.6M USD +41.3%
Net Cash Provided by (Used in) Financing Activities -15.1M USD -1018%
Net Cash Provided by (Used in) Investing Activities 49.2M USD +98%
Common Stock, Shares, Issued 143M shares -0.35%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 15.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37.1M USD -19.9%
Deferred Tax Assets, Valuation Allowance 162M USD -1.59%
Deferred Tax Assets, Gross 183M USD +9.75%
Operating Lease, Liability 6.97M USD -9.41%
Depreciation 4.85M USD +576%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -22M USD +71.3%
Lessee, Operating Lease, Liability, to be Paid 8.32M USD -11.8%
Property, Plant and Equipment, Gross 5.26M USD +0.27%
Operating Lease, Liability, Current 1.02M USD +3.88%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17M USD +2.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD +2.52%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.35M USD -22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.2M USD +2.48%
Deferred Tax Assets, Operating Loss Carryforwards 138M USD -2.21%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.23M USD +2.42%
Operating Lease, Payments 276K USD +4.94%
Amortization of Intangible Assets 800K USD -61.9%
Deferred Tax Assets, Net of Valuation Allowance 20.6M USD +1043%
Share-based Payment Arrangement, Expense 34.4M USD -14.9%
Interest Expense 5.19M USD +1743%